Who is Peter Pfreundschuh?

Executive Officer at Voyager Therapeutics, Inc.

Where does Peter Pfreundschuh work?

Peter Pfreundschuh is Executive at Voyager Therapeutics, Inc..

Where did Peter Pfreundschuh go to school?

Peter Pfreundschuh studied at Northwestern University ~ Kellogg School of Management (Masters Coursework in Strategic Marketing for the Healthcare Industry, MBA Marketing); Rider University Graduate School of Business (Masters in Business Administration, Concentrations in Finance & Marketing, MBA in Marketing and Finance); Rutgers University School of Business (Bachelor of Science in Accounting, Accounting & Economics).

Peter Pfreundschuh

Executive at Voyager Therapeutics, Inc.

Pittstown, New Jersey, United States

Find your path to Peter

377 people in our graph share verified history with Peter — schools, employers, funds. One of them is your warm intro.

Teresa ChanunlockedPeter: together at Johnson & Johnson (2002–2004)

Peter: together at Voyager Therapeutics, Inc.

×8Peter: together at Johnson & Johnson

×2Peter: together at AstraZeneca Pharmaceuticals L.P.

Executive at Voyager Therapeutics, Inc.

Intro paths

→

In turn, Peter can intro founders to Voyager Therapeutics, Inc.'s investors below.

Voyager Therapeutics, Inc.'s investors · 3

ARCH Venture PartnersChicago · $50K – $250M checks · since 2024 Fidelity InvestmentsBoston Third Rock VenturesBoston · $100K – $5M checks · since 2015

Experience

Panoma Therapeutics, Inc.Chairman & Chief Executive Officercurrent2026 — presentNew Jersey, United States
NorthStar Medical Technologies, LLCMember Board of Directorscurrent2024 — presentBeloit, Wisconsin, United States
Y-mAbs Therapeutics, Inc. (Sold to SERB Pharmaceuticals - September 2025)Executive Vice President - Chief Financial Officer2024 — 2025New Jersey, United States
Voyager Therapeutics, Inc.Chief Financial Officer & Senior Financial Advisor2022 — 2024Lexington, Massachusetts, United States
Frequency TherapeuticsChief Financial Officer2020 — 2022Greater Boston
UroGen Pharamceuticals Ltd.Chief Financial Officer2018 — 2020United States - New York
Sucampo Pharmaceuticals, Inc. (Sold to Mallinckrodt - February 2018)Chief Financial Officer2017 — 2018United States
Immunomedics Inc. (Sold to Gilead Sciences, Inc.)Vice President, Finance & Chief Financial Officer2013 — 2016300 The American Road, Morris Plains, New Jersey 07950
CircuLite Inc. (Sold to Heartware 2013)Chief Financial Officer/Corporate Officer2008 — 2013Saddle Brook, New Jersey
AstraZeneca Pharmaceuticals L.P.Executive Director Business Development & Licensing2007 — 2008Wilmington, Delaware
Johnson & JohnsonChief Financial Officer; Global Controller R&D & Business Development; Global Commercial Leader1999 — 2007New Jersey & Pennsylvania

Skills & more

CFOsTreasury ManagementCorporate M&AFinancial PlanningInvestor RelationsInvestment BankingBudgetingCEO/CFO CertificationStrategic PartnershipsMedical Devices17Corporate Finance7Business Development9

+8 more

Pharmaceutical IndustryStrategyManufacturingMergers & AcquisitionsLicensingHealthcareBiotechnologyLeadership

Certified Public Accountant — New Jersey Certified Public Accountants

From Peter's professional profile.

Frequently asked questions

Who is Peter Pfreundschuh?: Executive Officer at Voyager Therapeutics, Inc.
Where does Peter Pfreundschuh work?: Peter Pfreundschuh is Executive at Voyager Therapeutics, Inc..
Where did Peter Pfreundschuh go to school?: Peter Pfreundschuh studied at Northwestern University ~ Kellogg School of Management (Masters Coursework in Strategic Marketing for the Healthcare Industry, MBA Marketing); Rider University Graduate School of Business (Masters in Business Administration, Concentrations in Finance & Marketing, MBA in Marketing and Finance); Rutgers University School of Business (Bachelor of Science in Accounting, Accounting & Economics).